Arterial occlusive disease is the leading cause of death in Western countries. Core
contemporary therapies for this disease include angioplasties, stents, endarterectomies and …

Aims Optimal endovascular management of intermittent claudication (IC) remains disputed.
This systematic review and meta-analysis compares efficacy and safety outcomes for …

Critical limb ischemia, the final course of peripheral artery disease, is characterized by an
insufficient supply of blood flow and excessive oxidative stress. H2S molecular therapy …

Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …

Background: A clear patency benefit of a drug-eluting stent (DES) over bare metal stents
(BMSs) for treating peripheral artery disease of the femoropopliteal segment has not been …

Objectives This study sought to evaluate the safety and effectiveness of the Ranger drug-
coated balloon (DCB)(paclitaxel dose density 2 μg/mm2) for treating superficial femoral …

Controlled drug delivery is a matter of interest to numerous scientists from various domains,
as well as an essential issue for society as a whole. In the treatment of many diseases, it is …

Purpose: To report the 36-month outcomes from the prospective, multicenter, single-arm IN.
PACT Global Study (ClinicalTrials. gov identifier NCT01609296) evaluating the performance …

Abstract Aims Drug-coated balloons (DCBs) for femoropopliteal interventions have not been
tested against each other. We aimed to directly compare efficacy and safety of a high-dose …

Purpose This study aimed to assess 5-year effectiveness and safety of femoropopliteal
angioplasty with the Luminor® 35 drug-coated balloon (DCB). Materials and Methods The …